Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
A. Matsui, C. Spangler, J. Elferich, M. Shiozaki, N. Jean, X. Zhao, M. Qin, H. Zhong, Z. Yu, E. Gouaux
The paper develops methods to image glutamatergic synapses in hippocampal tissue using cryo-electron tomography, enabling high-resolution visualization of synaptic structures.
bioRxiv · Apr 1, 2024Biochemistry
S. Morita, K. Shigeta, P. Lei, T. Kobayashi, H. Kikuchi, A. Matsui, P. Huang, M. Pittet, D. Duda
This study shows that blocking CXCR4 and PD-1 together improves dendritic cell activation and immune responses against HCC in mouse models.
bioRxiv · Nov 6, 2023 · PreprintCancer Biology
S. Morita, T. Ando, H. Kikuchi, A. Morita, T. Kobayashi, G. Birch, R. Tanaka, A. Matsui, Z. Ruan, P. Huang, Y. Cho, A. Hernandez, J. W. Lee, E. M. Coyne, S. M. Shin, , D. G. Duda
Liver fibrosis limits the survival benefit of multikinase inhibitor immunotherapy in hepatocellular carcinoma by promoting innate immune-mediated hepatotoxicity despite preserved tumor control.
bioRxiv · Oct 20, 2023 · PreprintCancer Biology
J. Chen, Z. Amoozgar, X. LIU, S. Aoki, Z. Liu, S. Shin, A. Matsui, Z. Pu, P.-J. Lei, M. Datta, L. Zhu, Z. Ruan, L. Shi, D. Staiculescu, K. Inoue, , D. G. Duda
This paper shows that combining chemotherapy with CTLA-4 blockade reprograms the immune microenvironment of intrahepatic cholangiocarcinoma, enhancing the effectiveness of anti-PD1 therapy.
bioRxiv · Jan 26, 2023Cancer Biology
D. G. Duda, K. Inoue, D. H. Schanne, A. Matsui, P. Lei, S. Klein, S. Aoki, H. Taniguchi, H. Kikuchi, J. Chen, Z. Liu, S. Q. Tsai, T. C. Schmidt, M. Iwasaki, G. Geidel, , N. Bardeesy
The paper shows that the IFNA pathway promotes aggressive KRASG12D-mutant pancreatic ductal adenocarcinomas through IFNAR1/STAT3 activation and identifies IFNAR1 inhibition as a potential therapeutic strategy.
bioRxiv · Jun 29, 2022 · PreprintCancer Biology
Z. Pu, Z. Liu, J. Chen, K. Inoue, Z. Ruan, L. Zhu, H. Kikuchi, A. Matsui, P. Huang, D. G. Duda
This study tests an NLRP3 agonist added to PD-1/VEGFR inhibitors in murine HCC models with liver damage, finding it feasible but ineffective in improving tumor outcomes.
bioRxiv · Jun 23, 2022 · PreprintImmunology
R. Zhang, R. Kuo, M. Coulter, C. P. G. Calixto, J. C. Entizne, W. Guo, Y. Marquez, L. Milne, S. Riegler, A. Matsui, M. Tanaka, S. Harvey, G. Yubang, T. Wiebner-Kroh, M. Crespi, , J. W. Brown
This paper introduces a new Arabidopsis transcriptome dataset with improved accuracy and resolution using novel Iso-seq analysis methods, enhancing transcript expression and splicing analysis.
bioRxiv · Sep 2, 2021 · PreprintPlant Biology
K. Azuma, M. Sakamoto, S. Katayama, A. Matsui, K. Nakamichi, N. Goshima, S. Watanabe, J. Nakayama, K. Semba
This study shows HOXB7 promotes transformation and lung metastasis in NMuMG cells via STAT3 activation.
bioRxiv · May 16, 2021 · PreprintCancer Biology